AGP Executive Report
Last update: 9 hours agoPharma Manufacturing & Safety: At TIL Healthcare in Sri City, Andhra Pradesh, a boiler explosion killed at least five workers and injured 10 others; officials are probing a possible technical fault. Big Pharma Expansion: Bayer plans a $2.2B drug manufacturing site in New Albany, Ohio, targeting 600 jobs and production starting in 2031. Workforce Reshuffle: AstraZeneca is reportedly preparing layoffs in Spain, even as its Barcelona hub continues to expand. Dermatology Pipeline: Late-breaking phase 3 data for ritlecitinib (Tranquillo) show higher facial and total body repigmentation in nonsegmental vitiligo, with similar serious adverse event rates vs placebo. Public Health & Outbreaks: DRC officials say Ebola is past its peak, with deaths surpassing 4,000, while localized zones show no new cases for weeks. Healthcare Access: Nepal confirms 131 Japanese encephalitis cases and 28 deaths this year; vaccination campaigns are underway, alongside mosquito-bite precautions. Policy & Coverage: A new argument for universal public health insurance points to rising employer premium pressure and the risk of medical debt. Digital Health & Privacy: Apple’s iOS 27 adds major parental controls tied to child safety, while separate coverage warns that health-monitoring data from wearables can raise privacy concerns. Regulation: Pakistan’s medical regulator probe targets alleged MDCAT 2026 irregularities in Sindh, and Pakistan’s FCC clarifies doctors can prescribe for patients but can’t run drug outlets without a licence.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.